Global Antimicrobial Growth Promoters Market Overview:
Antimicrobial growth promoters are antibiotics supplementary to the feed of animal food that enhance their growth rate and productivity. AGPs helps in reducing normal intestinal flora and harmful gut bacteria. This industry is witnessing huge growth because of an increase in the combination of both fewer normal intestinal flora and fewer harmful bacteria. Some of the players profiled in the study are Cargill (United States), Royal DSM (Netherlands), Zoetis (United States), Alltech (United States), Elanco Animal Health (United States), Merck and Co. Inc. (United States), Vetoquinol (France), Bupo Animal Health (South Africa), CHR Hansen (United States) and Novus International Inc. (United States).
On the basis of geography, the market of Antimicrobial Growth Promoters has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sales Channels, the sub-segment i.e. Distributors will boost the Antimicrobial Growth Promoters market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Non-Antibiotics, the sub-segment i.e. Prebiotics & Probiotics will boost the Antimicrobial Growth Promoters market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Animals, the sub-segment i.e. Poultry will boost the Antimicrobial Growth Promoters market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Growth Drivers
- Rapid Development in the Global Meat Industry
- Increase In Alternatives to Antibiotics and Hormones and Growing Demand for Non-Antibiotic Growth Promoters
- Development in Animal Epidemics and Climate Changes
- Increase in Research and Development
- High Rivalry in the Industry
- Stringent Regulations That Prohibit the Usage of Antibiotics and Hormones for Growth Promotion in Animals
- Focus on Increasing Environment Sustainability
- The Rise in Pressure by the Usage of Glycopeptides as Growth Promoters
- High Cost Associated With the Global Feed Tonnage
The market is fragmented by key market players, and those are focusing on advanced production technologies, improving efficiency, and product life. With the increase in market growth opportunities that is captured by tracking the ongoing process improvement and financial flexibility to invest in business growth strategies.
Target Audience:Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Antimicrobial Growth Promoters Providers, Government Regulatory and Research Organizations and End-Use Industries
Major Objectives Focused through this Study To define, describe, and forecast the Global Antimicrobial Growth Promoters market on the basis of product [Antibiotic Growth Promoters and Non-Antibiotic Growth Promoters] , application [Animal Feed, Therapeutic Antimicrobial Drugs and Other], key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Antimicrobial Growth Promoters market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Antimicrobial Growth Promoters industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Vendors which are also part of the research are Associated British Foods (ABF) plc (United Kingdom), ERBER AG (United Kingdom) and Archer-Daniels-Midland Company (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Antimicrobial Growth Promoters market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.